Cargando…

Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study

BACKGROUND: Peritoneal carcinomatosis (PC) is a common evolution of abdominal cancers and is associated with poor prognosis. A few selected patients have option of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, but majority who are not eligible for curative approach can undergo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somashekhar, S. P., Ashwin, K. R., Kumar, C. Rohit, Rauthan, Amit, Rakshit, Sushmita H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	ORIGINAL ARTICLE: GI Cancers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348786/ https://www.ncbi.nlm.nih.gov/pubmed/30766848 http://dx.doi.org/10.4103/sajc.sajc_92_18

Ejemplares similares

Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer – study protocol for a randomized control trial
por: Somashekhar, S. P., et al.
Publicado: (2019)

Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy
por: Somashekhar, S.P., et al.
Publicado: (2018)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
por: S.P, Somashekhar, et al.
Publicado: (2021)

Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM)
por: Somashekhar, Sampige Prasanna, et al.
Publicado: (2020)

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2
por: Graversen, Martin, et al.
Publicado: (2018)

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Hübner, Martin, et al.
Publicado: (2017)

The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis
por: Deban, Mélina, et al.
Publicado: (2023)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure
por: Graversen, Martin, et al.
Publicado: (2018)

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
por: Kondo, A., et al.
Publicado: (1996)

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
por: Solass, Wiebke, et al.
Publicado: (2013)

Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis
por: Robella, Manuela, et al.
Publicado: (2016)

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly
por: Huang, Yeqian, et al.
Publicado: (2015)

Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022)

Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM)
por: Martin, David, et al.
Publicado: (2020)

Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis
por: Samadder, N Jewel, et al.
Publicado: (2023)

Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis
por: Nowacki, Maciej, et al.
Publicado: (2017)

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Teixeira Farinha, Hugo, et al.
Publicado: (2017)

Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis
por: Peignon, Grégory, et al.
Publicado: (2011)

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice
por: Kortüm, Benedikt, et al.
Publicado: (2015)

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
por: Zhao, Yue, et al.
Publicado: (2018)

Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates
por: Sievers, Chelsie K, et al.
Publicado: (2017)

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
por: Carotenuto, Pietro, et al.
Publicado: (2017)

RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis
por: Hilkens, John, et al.
Publicado: (2017)

Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture
por: Grillet, Fanny, et al.
Publicado: (2017)

Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity
por: Huang, Tu-Xiong, et al.
Publicado: (2022)

Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment
por: Pagano, Ester, et al.
Publicado: (2022)

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
por: Arechederra, Maria, et al.
Publicado: (2022)

Methionine deficiency facilitates antitumour immunity by altering m(6)A methylation of immune checkpoint transcripts
por: Li, Ting, et al.
Publicado: (2023)

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
por: Smyth, Elizabeth C, et al.
Publicado: (2021)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
por: Piso, Pompiliu, et al.
Publicado: (2004)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis
por: Ellison, Lynne M., et al.
Publicado: (2017)

Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers
por: Harris, Caleb, et al.
Publicado: (2019)

Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX
por: Ramaswamy, Anant, et al.
Publicado: (2019)

Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats
por: Otto, Jens, et al.
Publicado: (2007)

Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
por: Canda, Aras Emre, et al.
Publicado: (2018)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
por: Roh, Seung Jae, et al.
Publicado: (2020)

The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma
por: Khosrawipour, Tanja, et al.
Publicado: (2017)

The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis
por: FRANCESCUTTI, VALERIE, et al.
Publicado: (2013)

Systemic chemotherapy and short-course radiation in metastatic rectal cancers: A feasible paradigm in unresectable and potentially resectable cancers
por: Ostwal, Vikas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dssl08s6mgh4fdccjhrc432a42